Literature DB >> 10891898

Developmental apraxia arising from neonatal brachial plexus palsy.

T Brown1, C Cupido, H Scarfone, K Pape, V Galea, A McComas.   

Abstract

OBJECTIVE: To determine whether motor unit activation is impaired in patients with persisting disability arising from neonatal brachial plexus palsy (NBPP).
BACKGROUND: In NBPP patients, the authors previously found more extensive muscle reinnervation than might have been anticipated from the clinical examination.
METHODS: Motor skills were tested in a group of nine boys and seven girls with prior NBPP, who then underwent physiologic investigation of proximal and distal muscles in their affected and unaffected arms. The latter tests comprised measurements of maximal evoked muscle compound action potential (M-wave) amplitude, maximal voluntary torque, twitch torque, and twitch interpolation. A group of 17 children of similar ages served as control subjects.
RESULTS: In the NBPP group, motor skills were diminished and voluntary torque was reduced relative to M-wave amplitude and twitch torque. Moreover, interpolated twitches could be demonstrated in some NBPP patients but not in control subjects.
CONCLUSION: Persisting disability in NBPP patients is due, at least in part, to impaired motor unit activation. The authors suggest that the impairment is a form of developmental apraxia caused by defective motor programming in early infancy.

Entities:  

Mesh:

Year:  2000        PMID: 10891898     DOI: 10.1212/wnl.55.1.24

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  Obstetric brachial plexus palsy: treatment strategy, long-term results, and prognosis.

Authors:  Jörg Bahm; Claudia Ocampo-Pavez; Catherine Disselhorst-Klug; Bernd Sellhaus; Joachim Weis
Journal:  Dtsch Arztebl Int       Date:  2009-02-06       Impact factor: 5.594

Review 2.  Lyme disease--current state of knowledge.

Authors:  Roland Nau; Hans-Jürgen Christen; Helmut Eiffert
Journal:  Dtsch Arztebl Int       Date:  2009-01-30       Impact factor: 5.594

3.  Effects of Botulinum Toxin on Reducing the Co-contraction of Antagonists in Birth Brachial Plexus Palsy.

Authors:  Yong Beom Shin; Myung Jun Shin; Jae Hyeok Chang; Young Sun Cha; Hyun-Yoon Ko
Journal:  Ann Rehabil Med       Date:  2014-02-25

Review 4.  Hypothesis: Hughlings Jackson and presynaptic inhibition: is there a big picture?

Authors:  Alan J McComas
Journal:  J Neurophysiol       Date:  2016-04-27       Impact factor: 2.714

5.  How brachial plexus birth palsy affects motor development and upper extremity skill quality?

Authors:  Gülay Çelik; Tüzün Fırat
Journal:  Childs Nerv Syst       Date:  2021-07-01       Impact factor: 1.475

6.  'Wondering and waiting' after obstetrical brachial plexus injury: Are we underestimating the effects of the traumatic experience on the families?

Authors:  Carol DeMatteo; James R Bain; Deborah Gjertsen; Jessica A Harper
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

7.  Long-term outcome of accessory nerve to suprascapular nerve transfer in obstetric brachial plexus lesion: functional, morphological, and electrophysiological results.

Authors:  Matthias Gmeiner; Raffi Topakian; Manuel Göschl; Sarah Wurm; Anita Holzinger; Willem J R van Ouwerkerk; Kurt Holl
Journal:  Childs Nerv Syst       Date:  2015-06-26       Impact factor: 1.475

8.  Perinatal brachial plexus palsy.

Authors:  John Andersen; Joe Watt; Jaret Olson; John Van Aerde
Journal:  Paediatr Child Health       Date:  2006-02       Impact factor: 2.253

9.  Obstetric Brachial Plexus Palsy: Can a Unilateral Birth Onset Peripheral Injury Significantly Affect Brain Development?

Authors:  Egmar Longo; Ryota Nishiyori; Theresa Cruz; Katharine Alter; Diane L Damiano
Journal:  Dev Neurorehabil       Date:  2020-01-06       Impact factor: 2.308

Review 10.  Toward a narrower, more pragmatic view of developmental dyspraxia.

Authors:  Kyle J Steinman; Stewart H Mostofsky; Martha B Denckla
Journal:  J Child Neurol       Date:  2010-01       Impact factor: 1.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.